Literature DB >> 33975949

RAASI, NSAIDs, antidiabetics, and anticoagulants: More data needed to be labeled as harmful or neutral in SARS-CoV-2 infection.

Elisa Gremese1,2, Stefano Alivernini2, Gianfranco Ferraccioli3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33975949      PMCID： PMC8157936          DOI： 10.1073/pnas.2025609118

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  10 in total

1.  Misguided drug advice for COVID-19.

Authors:  Garret A FitzGerald
Journal:  Science       Date:  2020-03-20       Impact factor: 47.728

2.  Selective inhibition of thromboinflammation in COVID-19 by Btk inhibitors.

Authors:  Wolfgang Siess; Philipp Von Hundelshausen; Reinhard Lorenz
Journal:  Platelets       Date:  2020-09-06       Impact factor: 3.862

3.  Extracellular DNA traps promote thrombosis.

Authors:  Tobias A Fuchs; Alexander Brill; Daniel Duerschmied; Daphne Schatzberg; Marc Monestier; Daniel D Myers; Shirley K Wrobleski; Thomas W Wakefield; John H Hartwig; Denisa D Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-23       Impact factor: 11.205

4.  Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19.

Authors:  Giuseppe Mancia; Federico Rea; Monica Ludergnani; Giovanni Apolone; Giovanni Corrao
Journal:  N Engl J Med       Date:  2020-05-01       Impact factor: 91.245

Review 5.  Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review.

Authors:  Azita H Talasaz; Parham Sadeghipour; Hessam Kakavand; Maryam Aghakouchakzadeh; Elaheh Kordzadeh-Kermani; Benjamin W Van Tassell; Azin Gheymati; Hamid Ariannejad; Seyed Hossein Hosseini; Sepehr Jamalkhani; Michelle Sholzberg; Manuel Monreal; David Jimenez; Gregory Piazza; Sahil A Parikh; Ajay J Kirtane; John W Eikelboom; Jean M Connors; Beverley J Hunt; Stavros V Konstantinides; Mary Cushman; Jeffrey I Weitz; Gregg W Stone; Harlan M Krumholz; Gregory Y H Lip; Samuel Z Goldhaber; Behnood Bikdeli
Journal:  J Am Coll Cardiol       Date:  2021-03-11       Impact factor: 24.094

6.  The pathogenesis of microthrombi in COVID-19 cannot be controlled by DOAC: NETosis should be the target.

Authors:  E Gremese; G Ferraccioli
Journal:  J Intern Med       Date:  2021-01-10       Impact factor: 8.989

7.  A data-driven approach to identify risk profiles and protective drugs in COVID-19.

Authors:  Pietro E Cippà; Federica Cugnata; Paolo Ferrari; Chiara Brombin; Lorenzo Ruinelli; Giorgia Bianchi; Nicola Beria; Lukas Schulz; Enos Bernasconi; Paolo Merlani; Alessandro Ceschi; Clelia Di Serio
Journal:  Proc Natl Acad Sci U S A       Date:  2020-12-10       Impact factor: 11.205

8.  Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure.

Authors:  Milton Packer; Stefan D Anker; Javed Butler; Gerasimos Filippatos; Stuart J Pocock; Peter Carson; James Januzzi; Subodh Verma; Hiroyuki Tsutsui; Martina Brueckmann; Waheed Jamal; Karen Kimura; Janet Schnee; Cordula Zeller; Daniel Cotton; Edimar Bocchi; Michael Böhm; Dong-Ju Choi; Vijay Chopra; Eduardo Chuquiure; Nadia Giannetti; Stefan Janssens; Jian Zhang; Jose R Gonzalez Juanatey; Sanjay Kaul; Hans-Peter Brunner-La Rocca; Bela Merkely; Stephen J Nicholls; Sergio Perrone; Ileana Pina; Piotr Ponikowski; Naveed Sattar; Michele Senni; Marie-France Seronde; Jindrich Spinar; Iain Squire; Stefano Taddei; Christoph Wanner; Faiez Zannad
Journal:  N Engl J Med       Date:  2020-08-28       Impact factor: 176.079

9.  Neutrophil extracellular traps infiltrate the lung airway, interstitial, and vascular compartments in severe COVID-19.

Authors:  Coraline Radermecker; Nancy Detrembleur; Julien Guiot; Etienne Cavalier; Monique Henket; Céline d'Emal; Céline Vanwinge; Didier Cataldo; Cécile Oury; Philippe Delvenne; Thomas Marichal
Journal:  J Exp Med       Date:  2020-12-07       Impact factor: 14.307

10.  Direct oral anticoagulant use and risk of severe COVID-19.

Authors:  B Flam; V Wintzell; J F Ludvigsson; J Mårtensson; B Pasternak
Journal:  J Intern Med       Date:  2020-12-19       Impact factor: 13.068
  10 in total
  1 in total

1.  Reply to Gremese et al.: Statistical reasoning to evaluate treatment effects when data are collected with lack of design: Covid-19 experience.

Authors:  Clelia Di Serio; Pietro Cippà; Alessandro Ceschi; Paolo Ferrari
Journal:  Proc Natl Acad Sci U S A       Date:  2022-02-15       Impact factor: 11.205
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.